Aug 28, 2026 07:30AM
Aug 28, 2026 07:30AM
Aug 27, 2026 04:09PM
Aug 27, 2026 04:09PM
Aug 27, 2026 04:01PM
Aug 27, 2026 04:01PM
Jul 28, 2026 07:30AM Kazia files patent for paxalisib strategy in breast cancer
Jul 28, 2026 07:30AM
Jun 2, 2026 07:30AM
Jun 2, 2026 07:30AM
May 26, 2026 07:30AM
May 26, 2026 07:30AM
Apr 15, 2026 08:01AM
Apr 15, 2026 08:00AM Kazia Therapeutics Strengthens Scientific Leadership with Appointment of Dr. Sudha Rao as Chief Scientific Officer to Lead Next-Generation Oncology Platform
Apr 15, 2026 02:24AM
Apr 13, 2026 05:07PM
Apr 13, 2026 05:05PM
Jan 30, 2026 08:00AM
Jan 30, 2026 08:00AM
Jan 27, 2026 08:00AM
Jan 27, 2026 08:00AM Kazia Therapeutics Reports Encouraging Preliminary Clinical Responses in Ongoing Phase 1b Study of Paxalisib in Late-Stage Metastatic Triple-Negative Breast Cancer
Dec 10, 2025 08:03AM
Dec 10, 2025 08:00AM
Nov 19, 2025 09:46AM
Nov 18, 2025 04:15PM
Nov 18, 2025 04:15PM
Oct 28, 2025 06:43AM
Oct 27, 2025 07:16AM Kazia plans FDA meeting on glioblastoma drug regulatory pathway
Oct 27, 2025 07:15AM
Oct 7, 2025 08:33AM
Oct 7, 2025 08:30AM
Oct 2, 2025 08:31AM
Oct 2, 2025 08:30AM
Oct 1, 2025 09:21AM
Sep 11, 2025 08:01AM Kazia reports paxalisib disrupted cancer cell clusters in lab study
Sep 11, 2025 08:00AM
Jul 9, 2025 08:00AM
Jul 9, 2025 08:00AM
Jun 11, 2025 08:00AM
Jun 11, 2025 08:00AM
Jun 5, 2025 08:00AM
May 15, 2025 08:00AM Kazia Therapeutics Highlights Recent Progress and Provides Business Update
Mar 31, 2025 07:31AM
Mar 31, 2025 07:30AM
Feb 20, 2025 08:46AM
Feb 20, 2025 08:46AM
Jan 30, 2025 07:31AM
Jan 30, 2025 07:30AM
Jan 14, 2025 04:00PM Kazia Therapeutics Announces Closing of $2.0 Million Registered Direct Offering
Jan 10, 2025 10:01AM

329,911 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All